Female underrepresentation and adverse events reporting biases in lung cancer clinical trials: a systematic review and meta-analysis.

J Natl Cancer Cent · 2026 · PMC13250521 · PMID 42282126

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

an increasing trendno p-value reported

Female representation in lung cancer RCTs was inadequate (EID, −3.17%; 95% CI: −4.10, −2.24) ( Table 2 ), displaying an increasing trend before 2015, followed by a decreasing trend thereafter ( Fig. 2 ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.